Kidney International® Living Kidney Donors’ Healthcare Needs, Experiences and Perspectives Across Their Entire Donation Trajectory: A Semi-Structured, In-depth Interview Study This qualitative descriptive study examined the experiences of living kidney donors (LKDs) throughout care. It aimed to identify gaps in information and care as LKDs transitioned through different phases. The results reveal gaps in post-donation care for...
By Yannick Nlandu (DR Congo), YNC member and ISN-GKHA Named Fellow Most nephrologists dream of solving kidney health problems in their communities, typically requiring a more generalist approach to public health. However, nephrology programs in general, and in low-resource countries in particular, do not integrate this broad vision of kidney health. Nephrologists, therefore, need to...
Discover the "ISN Global Kidney Trials Insights: A Guide for Everyone," a new ISN initiative for people living with kidney diseases and others interested in kidney-related clinical trials. The project intends to foster meaningful communication between patients and kidney care practitioners and increase patient participation in clinical trials. Read the first study in the guide comparing...
This visual abstract was supported by an unrestricted educational grant from Chinook Therapeutics, a Novartis Company.
ISN mentee Priya Pais (back row, third from left) and ISN mentor Larry Greenbaum (front row, third from right) during his three-day visit to St John's National Academy of Health Sciences in Bangalore as part of their collaboration through the ISN Mentorship Program Through the ISN Mentorship Program, Larry Greenbaum, from the Emory University School...
Despite ongoing efforts, chronic kidney disease of unknown origin (CKDu) remains a significant, persistent challenge in several world regions. As part of its commitment to advancing equitable kidney care worldwide, the ISN launched the ISN i3C (CKDu) Network at WCN 2017 to facilitate global CKDu-related collaboration and data collection and dissemination. Explore the details of...
Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis The Kidney Disease: Improving Global Outcomes (KDIGO) has updated its Glomerular Diseases Guideline for lupus nephritis (LN) in response to accelerated drug development and new insights from genetic and molecular studies. Read the updated guideline here The most significant change involves...
Rumbidzai Dahwa received an ISN Clinical Research Program (CRP) grant for the research project "Prevalence of Chronic Kidney Disease in Zimbabwe" in 2017. Find out more about the CRP and how to apply here. The study, completed in 2020, was the first to provide comprehensive data on the nature and prevalence of dialysis in Zimbabwe and...
Read the application guidelines and eligibility criteria or apply directly here if you are an ISN member. Watch the webinar at the ISN Academy. The application deadline is May 1, but your ISN regional coordinator must review proposals by April 1. Find out who your regional coordinator is here. The ISN Clinical Research Program supports research and education initiatives that help detect and manage noncommunicable chronic diseases...
Despite ongoing efforts, chronic kidney disease of unknown origin (CKDu) remains a significant, persistent problem in several world regions. The ISN i3C (CKDu) Working Group has written a comprehensive position statement offering vital guidance and recommendations for kidney biopsies in individuals suspected of CKDu. Read "Kidney Biopsies Among Persons Living in Hotspots of CKDu: A...
Please join us in congratulating: Michele Provenzano for ISN-ACT (clinical trials) Anna Strasma for ISN i3C CKDu (chronic kidney disease of unknown origin) Winston Fung, Anukul Ghimire, Georgina Irish, Sabine Karam, Yannick Nlandu, Anna Petrova, Samveg Shah and Elliot Tannor for ISN-GKHA (Global Kidney Health Atlas) Get to know our ISN-Named Fellows here. These early-career ISN members were approved as...
By Andrea Viecelli As this year's chair of the ISN Young Nephrologists Committee's Capacity Building Sub-Committee, I had the opportunity to lead an amazing team of young kidney health professionals to build capacity and improve leadership skills, clinical workforce management, and research. Young nephrologists, particularly those practicing in low-income countries, have consistently acknowledged research as a...
Ensure you're well-equipped in the global effort to combat kidney diseases by exploring, utilizing and sharing these valuable ISN resources. CKD Early Identification & Intervention Toolkit To address the burden of chronic kidney disease (CKD) and its impact on global morbidity, the ISN and KDIGO collaborated on a series of tools for CKD early identification and...
Modules 5 and 6 of the CME-accredited ISN YNC Curriculum: Basics of Statistics for a Successful Start in Clinical Research are now available at the ISN Academy. Access Modules 5 and 6 now! (Join/renew your ISN membership to access this content) Module 5: Learn the applications of big data and machine learning in clinical research through...
Rupesh Raina, ISN-ACT Global Trials Focus Subgroup member, summarizes the design and outcomes of one of the team's latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The "Trial of the month" is available in several languages. Gravity-assisted Continuous Flow Peritoneal Dialysis Technique Use in Acute Kidney Injury in Children: A...
Precision medicine framework for optimizing CKD treatment Kidney International® Trends and Perspectives for Improving Quality of Chronic Kidney Disease Care: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference The conference discussed improving chronic kidney disease (CKD) diagnosis, care safety, and patient well-being, identifying current tools, barriers, and research needs in CKD management. Discussions acknowledged that...
From left to right: Caner Alparslan, ISN Young Nephrologists Committee member (Turkey); SWC faculty members Rümeyza Kazancioğlu (Turkey), Hans Peter Marti (Norway), and Zdenka Hruskova (Czech Republic); and host and BANTAO president Mustafa Arici (Turkey)* The ISN held a Scientific Writing Course (SWC) in Istanbul from October 5-7 at Istanbul University's central campus. During the three-day...
ISN-ACT Global Trials Focus Subgroup member Maria Chiara Pelle summarizes the design and outcomes of one of the ISN-ACT Global Trials Focus’ latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The “trial of the month” is available in several languages. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-risk Kidney Transplant...
Kidney International® A Prospective Controlled, Randomized Clinical Trial of Kidney Transplant Recipients Developed Personalized Tacrolimus Dosing Using Model-based Bayesian Prediction In this study, a population pharmacokinetic (PPK) model, incorporating factors such as genetics, age, and hematocrit, was developed and validated to optimize tacrolimus (Tac) dosage for kidney transplant recipients. PPK-based dosing was compared with traditional weight-based dosing....
The ISN is delighted to announce the results of its latest grant application period. We are pleased to welcome participants from fifteen countries worldwide: Six new ISN Fellows who will receive training to help them establish or improve local care in their home regions. The awardees are from Fiji, Kenya, Nigeria, the Solomon Islands and...